首页/数据集/Baseline characteristics of bDMARD naïve patients by cohort.

Baseline characteristics of bDMARD naïve patients by cohort.

Figshare2018-04-07 更新2026-04-29 收录

风湿病学

生物制剂疗效评估

数据链接：

https://figshare.com/articles/dataset/Baseline_characteristics_of_bDMARD_na_ve_patients_by_cohort_/6107315 数据链接链接失效反馈

官方服务：

资源简介：

Baseline characteristics of bDMARD naïve patients by cohort.

应用场景：

创建时间：

2018-04-07

相关数据集

cmcmaster/OpenHermes-2.5-Rheumatology

风湿病学

自然语言处理

--- dataset_info: features: - name: language dtype: string - name: topic dtype: string - name: hash sequence: int64 - name: model dtype: string - name: source dtype: st

Hugging Face2024-02-10 更新280

Association between IFX therapeutic response and patient characteristics.

生物制剂疗效评估

个体化预测

Association between IFX therapeutic response and patient characteristics.

Figshare2018-10-04 更新40

Dataset from Phase IIIb, Multinational, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of Certolizumab Pegol, a Pegylated Fab' Fragment of a Humanized Anti-Tumor Necrosis Factor(TNF)-Alpha Monoclonal Antibody, Administered in Subjects With Moderately to Severely Active Crohn's Disease.

克罗恩病药物

生物制剂疗效评估

The primary objective of the study is to evaluate efficacy of certolizumab pegol in inducing clinical remission in patients with moderate to severe Crohn's disease as compared with placebo based on Cr

NIAID Data Ecosystem10

Additional file 2: Table S2. of Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and rheumatoid arthritis

病毒学

风湿病学

Characteristics of 22 included studies. aDemographics of 57 RA patients and 16 other arthritides not stated, total population provided. bDetails not reported. cELISA (EA, VCA), immunofluorescence (EBN

Mendeley Data2024-06-29 更新110

Predictors of outcome in patients treated with Rituximab.

临床疗效预测

生物制剂疗效评估

Predictors of outcome in patients treated with Rituximab.

Figshare2017-03-03 更新20